HCA

HCA Healthcare
D

HCA

Arincen59/100B
495.02
USD
-12.39
(-2.44%)
Pre Open
Fair value430.99Plus+15%232Price 495.02597
Q4 FY2026 · Earnings report
EPS estimate 8.15Revenue estimate 20.02B
OverviewFinancialsNewsForecastEarningsDividendsCompany

HCA Healthcare revenue 1990–2026

HCA Healthcare's revenue in Q3 FY2026, the three months to 30 September 2026, was 19.85B USD, up 3.6% on the same quarter a year before. HCA Healthcare's revenue over the last twelve months was 78.70B USD, up 5.8% on the twelve months before. In fiscal year 2025 it was 75.60B USD, up 7.1% on the year before.

Last updated 7 Nov 2026 · Next report 26 Jan 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 202678.70B+5.82%17.07B6.78B
FY202531 Dec 202575.60B+7.08%31.37B6.78B
FY202431 Dec 202470.60B+8.67%28.68B5.76B
FY202331 Dec 202364.97B+7.86%25.58B5.24B
FY202231 Dec 202260.23B+2.52%23.18B5.64B
FY202131 Dec 202158.75B+14.01%22.49B6.96B
FY202031 Dec 202051.53B+0.38%43.16B3.75B
FY201931 Dec 201951.34B+9.98%42.86B3.51B
FY201831 Dec 201846.68B+7.02%38.95B3.79B
FY201731 Dec 201743.61B+5.12%36.30B2.22B
FY201631 Dec 201641.49B+4.57%34.56B2.89B
FY201531 Dec 201539.68B+7.48%33.04B2.13B
FY201431 Dec 201436.92B+8.00%30.66B1.88B
FY201331 Dec 201334.18B+3.54%28.21B1.56B
FY201231 Dec 201233.01B+1.56%27.30B1.61B
FY201131 Dec 201132.51B+5.94%24.50B2.47B
FY201031 Dec 201030.68B+2.10%23.07B1.21B
FY200931 Dec 200930.05B+5.91%25.18B1.05B
FY200831 Dec 200828.37B+5.64%23.75B673.00M
FY200731 Dec 200726.86B+5.42%22.46B874.00M
FY200631 Dec 200625.48B+4.18%21.16B1.04B
FY200531 Dec 200524.46B+4.05%20.33B1.42B
FY200431 Dec 200423.50B+7.77%19.60B1.25B
FY200331 Dec 200321.81B+10.54%0.001.33B
FY200231 Dec 200219.73B+9.89%0.00833.00M
FY200131 Dec 200117.95B+7.70%0.00886.00M
FY200031 Dec 200016.67B+0.08%0.00292.00M
FY199931 Dec 199916.66B-10.83%0.00740.00M
FY199831 Dec 199818.68B-0.73%0.00471.00M
FY199731 Dec 199718.82B-5.47%0.00-305.00M
FY199631 Dec 199619.91B+12.51%11.25B1.51B
FY199531 Dec 199517.70B+58.96%10.40B961.00M
FY199431 Dec 199411.13B+8.58%0.00630.00M
FY199331 Dec 199310.25B+1,246.11%6.74B507.00M
FY199231 Dec 1992761.60M+65.21%531.10M25.50M
FY199131 Dec 1991461.00M+69.11%325.70M15.20M
FY199031 Dec 1990272.60M—191.30M9.80M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

HCA Healthcare revenue growth by segment

Q3 FY2026 against Q3 FY2025

Managed Care And Other Insurers9.57B
+3.3%
Managed Medicare3.53B
+6.8%
Medicare2.93B
+7.2%
Medicaid1.77B
-1.0%
Managed Medicaid961.00M
+1.3%
International492.00M
+1.7%

HCA Healthcare revenue by segment over time

Managed Care And Other Insurers Managed Medicare Medicare Medicaid Managed Medicaid International
Fiscal yearManaged Care And Other InsurersManaged MedicareMedicareMedicaidManaged MedicaidInternational
FY202536.97B +5.8%13.44B +12.1%11.27B +4.6%5.91B +26.3%3.69B -7.2%1.86B +10.8%
FY202434.95B +9.9%11.99B +14.2%10.78B +1.8%4.68B +29.7%3.98B +2.6%1.68B +11.5%
FY202331.82B +9.3%10.50B +14.1%10.59B +1.3%3.61B +36.8%3.88B -3.0%1.51B +14.6%
FY202229.12B -3.9%9.20B +9.2%10.45B 0.0%2.64B +15.1%4.00B +28.0%1.32B -1.4%
FY202130.30B +14.2%8.42B +20.4%10.45B +0.3%2.29B +16.5%3.12B +19.2%1.34B +19.3%
FY202026.54B -0.0%7.00B +8.4%10.42B -3.5%1.97B +25.0%2.62B +7.0%1.12B -3.6%
FY201926.54B +8.5%6.45B +17.4%10.80B +9.8%1.57B +15.8%2.45B +2.0%1.16B +0.5%
FY201824.47B -1.4%5.50B +14.8%9.83B +3.7%1.36B -16.7%2.40B +2.3%1.16B +5.4%
FY201724.81B +5.9%4.79B +9.9%9.48B +6.6%1.63B +2.1%2.35B -5.2%1.10B -8.2%
FY201623.44B +7.1%4.36B +5.4%8.90B +2.8%1.60B -6.3%2.48B +10.9%1.20B -7.7%

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about HCA Healthcare's revenue

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.